CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation
Abstract Introduction: CORO1A, a constituent of the Coronins family, is a conserved protein throughout evolution that interacts with actin within…
Dilraba Elihamu
Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer
Abstract Introduction: The Bystin gene (BYSL) contributes to cancer development and is a probable therapeutic target in cancer therapy. However,…